HomeBCAX • NASDAQ
add
Bicara Therapeutics Inc
Previous close
$20.45
Day range
$19.66 - $21.30
Year range
$17.47 - $28.08
Market cap
1.02B USD
Avg Volume
325.57K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.63M | 116.45% |
Net income | -17.48M | 23.48% |
Net profit margin | — | — |
Earnings per share | -1.60 | — |
EBITDA | -20.61M | -116.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 520.76M | — |
Total assets | 524.17M | — |
Total liabilities | 14.62M | — |
Total equity | 509.56M | — |
Shares outstanding | 54.42M | — |
Price to book | 2.18 | — |
Return on assets | -14.07% | — |
Return on capital | -14.67% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -17.48M | 23.48% |
Cash from operations | -17.22M | -63.54% |
Cash from investing | -8.00K | 94.67% |
Cash from financing | 334.14M | 737.39% |
Net change in cash | 316.90M | 984.54% |
Free cash flow | -10.98M | — |
About
Founded
2018
Headquarters
Website
Employees
32
